Respiratory Monitoring Devices Market Size, Share, Growth, and Industry Analysis, By Type (Spirometry,Plethysmography,IOS/FOTS), By Application (Hospitals,Laboratories,Home Use), Regional Insights and Forecast to 2035

Respiratory Monitoring Devices Market Overview

The global Respiratory Monitoring Devices Market is forecast to expand from USD 22848.76 million in 2026 to USD 25028.53 million in 2027, and is expected to reach USD 51882.09 million by 2035, growing at a CAGR of 9.54% over the forecast period.

The Market Report highlights the rapid expansion of respiratory monitoring due to rising respiratory illnesses such as asthma, COPD, and post-COVID lung disorders. In 2024, over 545 million people worldwide suffered from chronic respiratory diseases, with COPD alone affecting 390 million patients, driving higher adoption of spirometry and plethysmography systems.

The Industry Report shows that global sales of spirometry devices exceeded 20 million units in 2024, while plethysmography systems recorded 15 million installations across hospitals and laboratories. Market Analysis indicates that 35% of respiratory monitoring devices are used in hospitals, 25% in laboratories, and 40% in home-care and other medical facilities. Future Market Forecast projects respiratory device penetration will increase sharply due to rising air pollution, which the WHO estimates is responsible for 7 million premature deaths annually.

Market Insights highlight the future opportunities of integrating AI-based respiratory monitoring and wireless sensors, which are expected to capture 30% of the market by 2030. Market Research Report reveals that 60% of manufacturers are shifting toward compact and digital respiratory monitoring systems. Industry Analysis confirms that respiratory monitoring demand will continue to grow due to increasing elderly population, with 1.5 billion people aged 65+ projected globally by 2030, making respiratory disorders more prevalent.

The USA Respiratory Monitoring Devices Market represents one of the largest global shares, with more than 80 million Americans affected by chronic respiratory diseases in 2024, including 25 million asthma patients and 16 million diagnosed with COPD. Market Analysis reveals that over 40% of U.S. hospitals deployed advanced respiratory monitoring systems in 2024, with 12 million spirometry units and 8 million plethysmography devices in active use. Market Report indicates that air pollution, smoking-related disorders, and post-pandemic complications drive steady adoption across hospitals, clinics, and laboratories.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 65% of respiratory device demand is driven by COPD, asthma, and lung infection cases worldwide.
• Major Market Restraint: 42% of regions face cost and affordability issues limiting access to respiratory devices.
• Emerging Trends: 58% of respiratory monitoring devices are moving toward AI-based and wireless sensor technologies.
• Regional Leadership: 38% of global demand is dominated by North America, with the USA holding the highest share.
• Competitive Landscape: 46% of global respiratory monitoring device sales are controlled by the top five manufacturers.
• Market Segmentation: 52% of devices are used in hospitals, 25% in laboratories, and 23% in home-care settings.
• Recent Development: 49% of manufacturers launched portable and compact respiratory monitoring devices in 2024.

Respiratory Monitoring Devices Market Latest Trends

The Respiratory Monitoring Devices Market Trends are shaped by rising chronic respiratory diseases, aging demographics, and technological integration. Market Report shows global spirometry device installations exceeded 20 million units in 2024, while plethysmography reached 15 million installations. Market Analysis highlights that 545 million patients globally live with chronic respiratory illnesses, with asthma affecting 262 million and COPD impacting 390 million patients. Market Research Report reveals that 30% of new devices launched in 2024 included wireless connectivity and AI-enabled diagnostic support.

Respiratory Monitoring Devices Market Dynamics

The Respiratory Monitoring Devices Market Dynamics are driven by healthcare demand, environmental factors, and technological transformation. Market Report reveals global demand exceeded 35 million units in 2024, with spirometry and plethysmography systems forming the majority. Market Analysis highlights that 65% of usage comes from hospitals, 25% from laboratories, and 10% from home-care and other medical facilities. Industry Report figures show that COPD and asthma cases combined drive 70% of the device usage worldwide.

DRIVER

"Rising prevalence of respiratory diseases is the primary driver of the Respiratory Monitoring Devices Market."

The Market Report highlights that chronic respiratory illnesses now affect more than 545 million people globally in 2024, with COPD alone impacting 390 million and asthma affecting 262 million patients. Market Analysis shows that respiratory monitoring devices, particularly spirometry and plethysmography, are essential diagnostic and management tools for these conditions. Industry Report data reveals that more than 20 million spirometry units and 15 million plethysmography systems were installed worldwide in 2024, marking a 17% growth in adoption.

RESTRAINT

"High costs and limited accessibility restrain growth of the Respiratory Monitoring Devices Market."

The Market Analysis highlights affordability as a critical restraint, with 42% of regions globally facing challenges in providing cost-effective respiratory monitoring solutions. Market Report indicates that in developing economies, only 30% of hospitals currently own spirometry devices, and less than 20% have access to plethysmography systems. Industry Report data reveals that while 20 million spirometry units are in circulation worldwide, access in rural healthcare centers remains below 15%, limiting widespread use.

OPPORTUNITY

"Integration of AI, telehealth, and portable devices presents major opportunities in the Respiratory Monitoring Devices Market."

The Market Research Report highlights that 58% of respiratory monitoring devices launched in 2024 included AI-based features, enabling predictive analytics and automated diagnostics. Market Analysis indicates telehealth adoption surged, with 35% of respiratory patients globally using remote monitoring tools in 2024, up from 20% in 2022. Industry Report figures show that hospitals accounted for 52% of demand, laboratories 25%, and home-care 23%, with the home-care segment representing a significant future opportunity.

CHALLENGE

"Supply chain, regulatory compliance, and technological barriers remain major challenges in the Respiratory Monitoring Devices Market."

Market Report findings reveal that despite 35 million respiratory monitoring devices in circulation in 2024, supply chain disruptions caused delays in 20% of device deliveries worldwide. Market Analysis shows that regulatory approvals remain a challenge, with 32% of new respiratory monitoring devices facing extended delays before entering global markets. Industry Report indicates that developing countries face infrastructure gaps, with less than 25% of hospitals equipped with reliable calibration and maintenance systems for respiratory monitoring devices.

Respiratory Monitoring Devices Market Segmentation

The Respiratory Monitoring Devices Market Segmentation highlights the growing diversity of demand across device types and applications. Market Report data shows that spirometry accounted for nearly 60% of global respiratory device usage in 2024, with plethysmography contributing 25%, and other monitoring devices making up the balance. Market Analysis indicates that over 20 million spirometry devices and 15 million plethysmography systems were installed globally in 2024, serving both hospitals and laboratories. Industry Report figures confirm that hospitals consumed 52% of the total devices, while laboratories accounted for 25% and home-care settings the remaining 23%.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Spirometry: Spirometry is the leading type of respiratory monitoring device, accounting for nearly 60% of global installations in 2024 and representing more than 20 million active devices. It is widely used to measure lung capacity, airflow, and breathing performance, supporting the diagnosis and management of asthma and COPD. Global chronic respiratory diseases affected more than 545 million people in 2024, creating strong demand for spirometry systems. Hospitals and laboratories remain major users, while portable and digital systems are increasingly adopted for home-based monitoring. The integration of wireless connectivity and AI-based diagnostic features is further improving usability, data analysis, and early respiratory disease detection.

Plethysmography: Plethysmography is an advanced respiratory monitoring technology used to measure lung volumes, airway resistance, and other detailed pulmonary parameters. According to the provided market information, plethysmography accounted for approximately 25% of the global Respiratory Monitoring Devices Market in 2024, with more than 15 million active installations. Its advanced diagnostic capabilities make it particularly important for hospitals, pulmonary laboratories, and specialized respiratory testing centers. Europe showed strong adoption, with more than 40% of laboratories using plethysmography systems in 2024, followed by North America at 35%. Increasing respiratory disease prevalence and demand for precise lung-function assessment are supporting adoption.

IOS/FOT: IOS/FOT, or Impulse Oscillometry System/Frequency Oscillation Technique, represents an advanced respiratory assessment approach used to evaluate airway resistance and respiratory function. The provided source does not specify a separate market share, installation volume, or growth percentage for IOS/FOT. However, it fits within the broader category of respiratory monitoring technologies serving patients with chronic respiratory conditions. The market data indicates that more than 545 million people worldwide experienced chronic respiratory diseases in 2024, supporting demand for advanced pulmonary assessment technologies. Increasing adoption of compact, digital, wireless, and AI-enabled respiratory monitoring systems is creating opportunities for technologies such as IOS/FOT in hospitals, laboratories, and specialized respiratory care settings.

BY APPLICATION

Hospitals: Hospitals represent the largest application segment of the Respiratory Monitoring Devices Market, accounting for approximately 52% of global demand in 2024. More than 18 million respiratory monitoring devices were active across hospital settings, supporting the diagnosis and management of asthma, COPD, lung cancer, respiratory infections, and post-COVID complications. Spirometry and plethysmography are widely used for pulmonary function testing and patient assessment. In the USA, more than 40% of hospitals deployed advanced respiratory monitoring systems in 2024. Increasing patient admissions, aging populations, and rising chronic respiratory diseases are encouraging hospitals to invest in advanced monitoring technologies. AI-enabled systems, wireless connectivity, and portable devices are further improving respiratory monitoring capabilities.

Laboratories: Laboratories accounted for approximately 25% of the Respiratory Monitoring Devices Market in 2024, representing more than 9 million installed devices worldwide. Respiratory and pulmonary laboratories rely heavily on advanced equipment for detailed lung-function assessment, disease diagnosis, clinical research, and patient monitoring. Plethysmography has particularly strong adoption in this segment because of its ability to provide detailed measurements of lung volumes and airway resistance. According to the provided market data, approximately 65% of plethysmography usage is concentrated in laboratory settings. Europe leads laboratory adoption, with around 40% of respiratory research laboratories using plethysmography in 2024, followed by North America at 35%. Growing respiratory disease prevalence and demand for accurate diagnostic testing continue to support laboratory adoption.

Home Use: Home use is becoming an increasingly important application area for respiratory monitoring devices as healthcare providers expand remote patient monitoring and telehealth services. The provided market data indicates that home-care and other medical facilities accounted for approximately 23% of respiratory monitoring device demand in 2024. The increasing prevalence of chronic respiratory diseases, including asthma and COPD, is encouraging patients to monitor respiratory conditions outside hospitals. Portable spirometry devices, wireless sensors, and connected monitoring systems are supporting this transition. Telehealth adoption also increased significantly, with approximately 35% of respiratory patients globally using remote monitoring tools in 2024, compared with 20% in 2022. Compact devices and digital connectivity are expected to further strengthen home-based respiratory monitoring.

Regional Outlook of the Respiratory Monitoring Devices Market

The global Respiratory Monitoring Devices Market Outlook varies significantly across North America, Europe, Asia-Pacific, and the Middle East & Africa, reflecting differences in healthcare infrastructure, patient demographics, pollution levels, and technological adoption. Market Report insights confirm that over 35 million respiratory devices were in use globally in 2024, with North America holding 38% of the market share, Europe 25%, Asia-Pacific 30%, and the Middle East & Africa 7%. Market Analysis highlights that regional demand is influenced by chronic respiratory disease prevalence, with COPD and asthma cases highest in Asia-Pacific and North America.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

The North America Respiratory Monitoring Devices Market dominated global share in 2024 with 38% of total demand, equivalent to more than 13 million devices. Market Report shows that the USA alone accounted for 80 million patients with chronic respiratory diseases, including 25 million with asthma and 16 million with COPD. Market Analysis highlights that Canada contributed nearly 7 million cases, while Mexico recorded 10 million, pushing overall regional demand higher.

EUROPE

The Europe Respiratory Monitoring Devices Market accounted for 25% of global share in 2024, representing nearly 9 million devices. Market Report highlights that COPD prevalence reached 36 million cases across Europe in 2023, while asthma impacted over 30 million people, fueling device demand. Market Analysis indicates that Germany, the UK, and France are leading markets, collectively consuming 45% of regional respiratory monitoring devices.

ASIA-PACIFIC

The Asia-Pacific Respiratory Monitoring Devices Market accounted for 30% of global demand in 2024, representing over 10 million devices. Market Report highlights that Asia-Pacific is home to the largest patient population, with more than 300 million people suffering from chronic respiratory conditions, including 90 million in China and 40 million in India. Market Analysis shows that rapid urbanization and pollution have worsened conditions, with air pollution linked to 2 million deaths annually in the region.

MIDDLE EAST & AFRICA

The Middle East & Africa Respiratory Monitoring Devices Market represented 7% of global demand in 2024, equivalent to around 2.5 million devices. Market Report shows COPD prevalence reached 15 million cases across the region, while asthma impacted nearly 20 million patients, especially in urban centers. Market Analysis highlights that South Africa, Saudi Arabia, and the UAE are the leading adopters, with hospitals accounting for 65% of demand.

List of Top Respiratory Monitoring Devices Companies

• Masimo Corporation
• ResMed, Inc.
• Smiths Medical
• CareFusion Corporation
• COSMED

Masimo Corporation: Masimo Corporation is a leading player in the Respiratory Monitoring Devices Market, specializing in innovative non-invasive monitoring technologies. Market Report data shows that Masimo’s advanced pulse oximeters and capnography systems were installed in more than 200,000 hospital settings globally in 2024. Market Analysis highlights that 40% of U.S. hospitals currently deploy Masimo’s respiratory monitoring solutions, making it one of the most trusted providers.

ResMed, Inc.: ResMed, Inc. is globally recognized for its leadership in sleep apnea and respiratory care devices. Market Report indicates that ResMed served more than 140 million patients worldwide in 2024 through its respiratory and sleep monitoring solutions. Market Analysis shows that the company sold over 18 million respiratory monitoring units by 2024, with strong adoption in North America, Europe, and Asia-Pacific.

Investment Analysis and Opportunities

The Respiratory Monitoring Devices Market Investment Analysis highlights strong growth opportunities across hospitals, laboratories, and home-care settings. Market Report confirms that global demand exceeded 35 million units in 2024, with spirometry and plethysmography dominating sales. Market Analysis shows that 65% of usage came from hospitals, 25% from laboratories, and 10% from home-care. Industry Report figures reveal that North America controlled 38% of the market, Europe 25%, Asia-Pacific 30%, and Middle East & Africa 7%. Market Insights highlight that investment opportunities lie in AI-powered devices, as 58% of new products launched in 2024 integrated AI or predictive analytics. Market Research Report shows that telehealth-enabled respiratory devices already serve 35% of patients globally, projected to reach 70% by 2030.

New Product Development

The Respiratory Monitoring Devices Market is undergoing rapid innovation in product development, with new technologies reshaping patient care. Market Report highlights that 30% of devices launched in 2024 included wireless and AI-based features. Market Analysis indicates that spirometry devices are becoming portable, with 25% of new units in 2024 being smartphone-compatible. Industry Report shows plethysmography is advancing, with 15% of devices incorporating AI-powered diagnostic accuracy tools. Market Insights emphasize that hospitals adopted predictive respiratory monitoring devices in 45% of cases in 2024, improving early disease detection.

Five Recent Developments

• In 2024, more than 35 million respiratory monitoring devices were installed worldwide, marking a 15% increase compared to 2023.
• Telehealth-enabled respiratory devices reached 35% of global patient usage in 2024, compared to 20% in 2022.
• Masimo introduced AI-powered monitoring solutions in 2024, covering 30% of its product launches.
• ResMed connected more than 15 million patients to its cloud-based monitoring systems in 2024, strengthening digital healthcare.
• Portable spirometry device sales surged 25% in 2024, with 12 million new units installed across hospitals and home-care facilities.

Report Coverage of Respiratory Monitoring Devices Market

The Respiratory Monitoring Devices Market Report provides comprehensive coverage of market size, adoption patterns, and technological advancements across regions. Market Analysis confirms that in 2024, global demand exceeded 35 million respiratory monitoring devices, with spirometry accounting for 20 million units and plethysmography 15 million units. Market Report highlights that COPD prevalence reached 390 million cases and asthma 262 million worldwide, directly influencing demand. Industry Report shows North America accounted for 38% of global market share, followed by Europe at 25% and Asia-Pacific at 30%.

Respiratory Monitoring Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 22848.76 Million in 2026
Market Size Value By	USD 51882.09 Million by 2035
Growth Rate	CAGR of 9.54% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Spirometry Plethysmography IOS/FOT By Application : Hospitals Laboratories Home Use
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample